BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 31096934)

  • 1. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
    BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
    van de Wal M; Thewes B; Gielissen M; Speckens A; Prins J
    J Clin Oncol; 2017 Jul; 35(19):2173-2183. PubMed ID: 28471726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
    van Helmondt SJ; van der Lee ML; de Vries J
    BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors.
    Lyhne JD; Smith A'B; Frostholm L; Fink P; Jensen LH
    BMC Cancer; 2020 Mar; 20(1):223. PubMed ID: 32178640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of CBT-based online self-help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial.
    van Helmondt SJ; van der Lee ML; van Woezik RAM; Lodder P; de Vries J
    Psychooncology; 2020 Jan; 29(1):86-97. PubMed ID: 31595627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of an intervention to reduce fear of cancer recurrence: The ConquerFear randomized controlled trial.
    Shih ST; Butow P; Bowe SJ; Thewes B; Turner J; Gilchrist J; Mihalopoulos C;
    Psychooncology; 2019 May; 28(5):1071-1079. PubMed ID: 30860653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors.
    Luigjes-Huizer YL; van der Lee ML; de Wit NJ; Helsper CW
    BMJ Open; 2019 Dec; 9(12):e032616. PubMed ID: 31796488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
    Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
    Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
    Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
    BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of an individual blended cognitive behavioral therapy to reduce psychological distress among distressed colorectal cancer survivors: The COloRectal canceR distrEss reduCTion trial.
    Custers JAE; Kwakkenbos L; Levis B; Döking S; van der Hoeven YCW; Leermakers L; de Wilt JHW; Thewes B; Braamse AMJ; Dekker J; Prins JB
    Psychooncology; 2024 Jan; 33(1):e6270. PubMed ID: 38117026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBT-based Online Self-help Training to Reduce Fear and Distress After Cancer (CAREST Randomized Trial): 24 Months Follow-up Using Latent Growth Models and Latent Class Analysis.
    van Helmondt SJ; Lodder P; van Woezik R; de Vries J; van der Lee ML
    Ann Behav Med; 2023 Aug; 57(9):787-799. PubMed ID: 37078920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.
    Romijn G; Batelaan N; Koning J; van Balkom A; de Leeuw A; Benning F; Hakkaart van Roijen L; Riper H
    PLoS One; 2021; 16(11):e0259493. PubMed ID: 34767575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the WHI LILAC study.
    Krok-Schoen JL; Naughton MJ; Bernardo BM; Young GS; Paskett ED
    Psychooncology; 2018 Jul; 27(7):1810-1815. PubMed ID: 29644766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.
    Tomei C; Lebel S; Maheu C; Lefebvre M; Harris C
    Support Care Cancer; 2018 Aug; 26(8):2751-2762. PubMed ID: 29500582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the validation of a new, blended theoretical model of fear of cancer recurrence.
    Lebel S; Maheu C; Tomei C; Bernstein LJ; Courbasson C; Ferguson S; Harris C; Jolicoeur L; Lefebvre M; Muraca L; Ramanakumar AV; Singh M; Parrott J; Figueiredo D
    Psychooncology; 2018 Nov; 27(11):2594-2601. PubMed ID: 30180279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and Effectiveness of Blended Versus Standard Cognitive Behavioral Therapy for Outpatients With Depression in Routine Specialized Mental Health Care: Pilot Randomized Controlled Trial.
    Kooistra LC; Wiersma JE; Ruwaard J; Neijenhuijs K; Lokkerbol J; van Oppen P; Smit F; Riper H
    J Med Internet Res; 2019 Oct; 21(10):e14261. PubMed ID: 31663855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence.
    Butow PN; Bell ML; Smith AB; Fardell JE; Thewes B; Turner J; Gilchrist J; Beith J; Girgis A; Sharpe L; Shih S; Mihalopoulos C;
    BMC Cancer; 2013 Apr; 13():201. PubMed ID: 23617696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms.
    Verbeek JGE; Atema V; Mewes JC; van Leeuwen M; Oldenburg HSA; van Beurden M; Hunter MS; van Harten WH; Aaronson NK; Retèl VP
    Breast Cancer Res Treat; 2019 Dec; 178(3):573-585. PubMed ID: 31451978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
    Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
    Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.